semaglutide ending FDA ends shortage, closing the door on compounded Wegovy, Ozempic Judge Upholds FDA Deadline Ending

Lifestyle changes for perimenopause Were all familiar with the tried-and-true healthy lifestyle recommendations eating plenty of veggies and sticking to whole foods, getting sufficient sleep, limiting alcohol, avoiding tobacco, reducing stress, exercising regularly (both aerobic and weight-bearing)

While AMH testing can help estimate how close you may be to menopause, sometimes within a window of a few years, its mostly used in research settings and not currently recommended as a standard tool to diagnose perimenopause

Govaert, B., Melenhorst, J., van Gemert, W

Clinical Trial Outcomes Retatrutide is a triple hormone receptor agonist that was studied for its impact on liver fat and metabolic health in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD)

Your Ivm Health team provides ongoing support through FSA and/or HSA eligible GLP-1 weight loss strategies including: Regular appointments to check progress Medication dosage review and adjustments as needed Lifestyle support and modification guidance Holistic nutritional and exercise recommendations Ongoing treatment plan reviews and updates Its important to check with your FSA or HSA plan administrator to determine if funds may be used to pay for prescription GLP-1 medications

In 2023, it was estimated that 12,220 new cases of BTC would be diagnosed in the U.S